Advanced Stage Hepatocellular Carcinoma with Multiple Metastasis and Vascular Thrombosis: A Case of Complete Response to Sorafenib

Sorafenib is a multi-targeted tyrosine kinase inhibitor, with antiangiogenic and antiproliferative properties, approved for the treatment of advanced hepatocellular carcinoma. It induces a significant increase in the median overall survival, despite a complete response to treatment being rare. We re...

Full description

Bibliographic Details
Main Author: Simão, Adélia (author)
Other Authors: Silva, Raquel (author), Correia, Lurdes (author), Alves, Filipe Caseiro (author), Carvalho, Armando (author), Costa, J. M. Nascimento (author)
Format: article
Language:eng
Published: 2016
Subjects:
Carcinoma
Hepatocellular/drug therapy
Neoplasm Metastasis
Remission Induction
Sorafenib.
Carcinoma Hepatocelular/quimioterapia
Indução de Remissão
Metástase Neoplásica
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6799
Country:Portugal
Oai:oai:ojs.www.actamedicaportuguesa.com:article/6799

Internet

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6799

Similar Items